top of page
Search


Great Boulder Resources (ASX: GBR) Advances Toward Gold Mining with Robust Ironbark Study - Why this is Now a No Brainer for Investors.
Great Boulder Resources Ltd (ASX:GBR) is moving confidently into the second half of 2025. In the span of just two weeks, the Company has expanded the mineralised footprint at Side Well, announced significant new gold intersections at Ironbark, and secured $12.5 million in funding to accelerate its exploration strategy.

Noel Ong
Aug 38 min read


Coffee with Samso - An Emerging Gold Mining Story | Horizon Minerals Limited (ASX: HRZ).
Coffee with Samso Episode 207 is all about a company that is feeling left behind in the midst of a unprecedented gold price rush. Gold miners, the producing companies on the ASX, are all buoyant and experiencing an emotional high on valuation. Shareholders are in a state of euphoria but in the rush, there are always some hidden value. The hidden value that is typically brushed aside by the juggernaut of cash producing gold miners speeding past the sights of investors.

Noel Ong
Aug 16 min read


Cyclone Metals (ASX: CLE) Powers Ahead – Iron Bear Gathers Pace with Renewables, Vale Support, and Premium Iron Outputs - The Business of Green Iron Ore approaches Monetisation.
Cyclone Metals Limited (ASX: CLE) has released its Quarterly Activities Report for the period ending 30 June 2025, and the momentum behind the Iron Bear Project is evident. Backed by a strategic partnership with Vale S.A., the quarter saw the completion of critical technical studies, advancement in metallurgical testing, progress across engineering and environmental baselines, and tangible steps toward the upcoming Scoping Study and PFS.

Noel Ong
Jul 317 min read


AML3D Limited (ASX: AL3) Powers Ahead: Portable ARCEMY Order and US Defence Expansion Signal Scale-Up Success - The Business of 3D Printing.
AML3D Limited (ASX: AL3) continues to solidify its reputation as a key enabler of defence manufacturing transformation. Over the June 2025 quarter, the company advanced its “US Scale Up” strategy with concrete progress in strategic partnerships, facility expansion, and order momentum. With a freshly announced order for a portable ARCEMY® system and a strong quarterly cash position of A$30.4 million, AML3D is not just building metal parts, but reshaping how defence manufacturi

Noel Ong
Jul 295 min read


PromarkerD Gains US Billing Code as WA Facility Secures $6M Boost – A Dual Leap for Proteomics International (ASX: PIQ) - The Business of Predictive and Diagnostic Blood Test.
Proteomics International Laboratories Ltd (ASX: PIQ), a recognised pioneer in precision diagnostics, has announced a significant development for the Western Australian scientific and medical landscape: a $6 million funding boost to expand the WA Proteomics Facility. This strategic investment will be delivered over three years, with contributions from the WA State Government, Bioplatforms Australia, the University of Western Australia (UWA), and Proteomics International itself

Noel Ong
Jul 287 min read


Ausgold Limited (ASX: AUC) – Katanning Gold Project DFS Confirms Long-Life, High-Margin Gold Mining Operation.
Ausgold Limited (ASX: AUC) has delivered a definitive milestone with the release of its Definitive Feasibility Study (DFS) for the 100%-owned Katanning Gold Project (KGP). The study validates KGP as one of Australia’s most advanced undeveloped open-pit gold projects, combining scale, near-term development potential, and robust economics within a Tier-1 jurisdiction

Noel Ong
Jul 276 min read


Mesoblast and FDA Align on Key Steps Toward Revascor® BLA Filing - A Solution for Chronic Heart Failure.
Mesoblast Limited (ASX: MSB | Nasdaq: MESO) has taken a critical step toward commercialising its lead cardiac product candidate, Revascor® (rexlemestrocel-L), with formal alignment reached with the United States Food and Drug Administration (FDA) on the key requirements for filing a Biologics License Application (BLA) in the treatment of ischemic heart failure with reduced ejection fraction (HFrEF) and inflammation.

Noel Ong
Jul 245 min read


NeuroScientific Biopharmaceuticals (ASX: NSB) – A Breakthrough in Stem Cell Technology Aimed at Refractory Crohn’s and Beyond.
NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) has taken a major strategic step by acquiring StemSmart™, a globally patented and clinically validated stem cell platform. This acquisition adds a powerful, next-generation therapeutic capability to the company’s focus on neuroimmune and inflammatory diseases.

Noel Ong
Jul 238 min read


Lightning Minerals Expands Gold and Copper Portfolio Through Strategic Acquisition.
30 June 2025 – Lightning Minerals Ltd (ASX: L1M) has announced a transformational acquisition of two advanced brownfields projects targeting gold and copper in Queensland (Mt Turner Projects) and New South Wales (Lachlan Fold Copper Porphyry Project). The acquisition of Lotus Minerals Pty Ltd significantly strengthens the Company’s portfolio and introduces immediate drill targets in some of Australia’s most mineral-endowed regions.

Noel Ong
Jul 237 min read


OpenLearning Gaining Ground in Australia and the Philippines with Back-to-Back SaaS Deals - An Business in Education.
OpenLearning Limited (ASX: OLL) has secured two strategic SaaS agreements in quick succession, expanding its reach in both Southeast Asia and Australia. The first, a A$495,000 deal with CE-Logic Inc. in the Philippines and a 5-year A$155,000 agreement with the Education Centre of Australia. Together, these wins underscore OpenLearning’s growing momentum across key education markets.

Noel Ong
Jul 236 min read
bottom of page
